| 1 |
27282281 | miR-222 confers the resistance of breast cancer cells to Adriamycin through suppression of p27(kip1) expression. | 2016 Sep 15 |
1 |
| 2 |
27699665 | miR-222 induces Adriamycin resistance in breast cancer through PTEN/Akt/p27kip1 pathway. | 2016 Nov |
1 |
| 3 |
20716117 | The roles of p27(Kip1) and DNA damage signalling in the chemotherapy-induced delayed cell cycle checkpoint. | 2010 Sep |
1 |
| 4 |
20736003 | Inhibition of phosphatidylinositol 3-kinase promotes tumor cell resistance to chemotherapeutic agents via a mechanism involving delay in cell cycle progression. | 2010 Nov 15 |
1 |
| 5 |
10810365 | P27KiP1 overexpression inhibits the growth and doxorubicin sensitivity of HT29 human colon cancer cells in vivo. | 2000 Mar-Apr |
2 |
| 6 |
9688315 | Contribution of the cyclin-dependent kinase inhibitor p27KIP1 to the confluence-dependent resistance of HT29 human colon carcinoma cells. | 1998 Aug 31 |
1 |